Relationship of four vitamin D receptor gene polymorphisms with type 1 diabetes mellitus susceptibility in Kuwaiti children

Majedah A Rasoul 1 2, Mohammad Z Haider 3, Maria Al-Mahdi 2, Hessa Al-Kandari 4 5, Gursev S Dhaunsi 1 6

Affiliations

01 March 2019

-

doi: 10.1186/s12887-019-1448-0

Abstract

Background: The incidence of type 1 diabetes mellitus (T1DM) in Kuwait is amongst the highest in the world. Vitamin D is considered to be involved in immune modulation and its deficiency contribute to autoimmune destruction of insulin producing beta cells in T1DM patients. Vitamin D has been shown to exert its effects via a nuclear vitamin D receptor (VDR) and therefore, VDR gene may be considered a candidate for T1DM susceptibility.

Methods: The genotypes of four VDR gene polymorphisms were determined in 253 Kuwaiti Arab T1DM patients and 214 healthy controls by PCR-RFLP analysis. Serum concentrations of three autoantibodies i.e. ICA (Islet cell autoantibody), GADA (Glutamic acid decarboxylase) and INS (Insulin autoantibody) were determined by radio-immunoassays.

Results: Statistically significant differences were detected between the genotypes of two VDR gene polymorphisms (FokI, C > T, rs10735810 and TaqI, C > T, rs731236) between T1DM patients and controls (P < 0.0001). In both, the frequency of variant alleles was considerably high in T1DM than in the controls. In contrast, the VDR gene ApaI (G > T, rs7975232) and BsmI (A > G, rs1544410) polymorphisms did not show association with T1DM. The homozygous variant genotypes of FokI, ApaI and TaqI polymorphisms show significant differences between various age-of-onset subgroups while no such association was detected in the case of BsmI polymorphism. Significant differences were also noted between heterozygous genotypes of all four polymorphisms especially between 4-6y and > 6y age-of-onset subgroups of T1DM patients. Three autoantibodies, ICA (Islet cell), GADA (glutamate decarboxylase) and INS (insulin) were positively associated to, varying degrees, with T1DM in Kuwaiti Arabs harboring different VDR gene polymorphism genotypes.

Conclusions: Our results demonstrate a significant effect of two VDR gene polymorphisms (FokI and TaqI) and three autoantibodies on genetic susceptibility of T1DM in Kuwaiti Arabs along with other factors.

Keywords: Autoantibody; Genotype; Kuwait; Polymorphism; Type 1 diabetes mellitus; Vitamin D receptor gene.

Conflict of interest statement

Consent for publication

Not applicable.

Similar articles

Association of protein tyrosine phosphatase non-receptor type 22 gene functional variant C1858T, HLA-DQ/DR genotypes and autoantibodies with susceptibility to type-1 diabetes mellitus in Kuwaiti Arabs.

Haider MZ, Rasoul MA, Al-Mahdi M, Al-Kandari H, Dhaunsi GS.PLoS One. 2018 Jun 20;13(6):e0198652. doi: 10.1371/journal.pone.0198652. eCollection 2018.PMID: 29924845 Free PMC article.

Vitamin D status and vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Egyptian children.

Abd-Allah SH, Pasha HF, Hagrass HA, Alghobashy AA.Gene. 2014 Feb 25;536(2):430-4. doi: 10.1016/j.gene.2013.12.032. Epub 2013 Dec 23.PMID: 24370753

Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population.

Chang TJ, Lei HH, Yeh JI, Chiu KC, Lee KC, Chen MC, Tai TY, Chuang LM.Clin Endocrinol (Oxf). 2000 May;52(5):575-80. doi: 10.1046/j.1365-2265.2000.00985.x.PMID: 10792336

Contribution of VDR polymorphisms to type 1 diabetes susceptibility: Systematic review of case-control studies and meta-analysis.

Tizaoui K, Kaabachi W, Hamzaoui A, Hamzaoui K.J Steroid Biochem Mol Biol. 2014 Sep;143:240-9. doi: 10.1016/j.jsbmb.2014.03.011. Epub 2014 Apr 15.PMID: 24742873 Review.

A meta-analysis of association of vitamin D receptor BsmI gene polymorphism with the risk of type 1 diabetes mellitus.

Qin WH, Wang HX, Qiu JL, Huang XB, Huang Y, Wu NR, Liang HS.J Recept Signal Transduct Res. 2014 Oct;34(5):372-7. doi: 10.3109/10799893.2014.903420. Epub 2014 Mar 25.PMID: 24665917 Review.

Cited by

Vitamin D receptor gene polymorphisms are associated with the risk and features of myasthenia gravis in the Han Chinese population.

Dai Y, Wu F, Ni S, Guo S, Lu L, Zhao X.Immunol Res. 2023 Jun;71(3):404-412. doi: 10.1007/s12026-022-09349-x. Epub 2023 Jan 7.PMID: 36609978

Vitamin D and Beta Cells in Type 1 Diabetes: A Systematic Review.

Yu J, Sharma P, Girgis CM, Gunton JE.Int J Mol Sci. 2022 Nov 20;23(22):14434. doi: 10.3390/ijms232214434.PMID: 36430915 Free PMC article. Review.

Progress in the Relationship between Vitamin D Deficiency and the Incidence of Type 1 Diabetes Mellitus in Children.

He LP, Song YX, Zhu T, Gu W, Liu CW.J Diabetes Res. 2022 Sep 2;2022:5953562. doi: 10.1155/2022/5953562. eCollection 2022.PMID: 36090587 Free PMC article. Review.

Single-nucleotide polymorphisms as important risk factors of diabetes among Middle East population.

Akhlaghipour I, Bina AR, Mogharrabi MR, Fanoodi A, Ebrahimian AR, Khojasteh Kaffash S, Babazadeh Baghan A, Khorashadizadeh ME, Taghehchian N, Moghbeli M.Hum Genomics. 2022 Apr 2;16(1):11. doi: 10.1186/s40246-022-00383-2.PMID: 35366956 Free PMC article. Review.

Variants in the VDR Gene May Influence 25(OH)D Levels in Type 1 Diabetes Mellitus in a Brazilian Population.

Ferraz RS, Silva CS, Cavalcante GC, de Queiroz NNM, Felício KM, Felício JS, Ribeiro-Dos-Santos Â.Nutrients. 2022 Feb 27;14(5):1010. doi: 10.3390/nu14051010.PMID: 35267984 Free PMC article.

KMEL References

https://pubmed.ncbi.nlm.nih.gov/

References

  1.  
    1. Shaltout AA, Wake D, Thanaraj TA, Omar DM, Al-AbdulRazzaq D, Channanath A, et al. Incidence of type-1 diabetes has doubled in Kuwaiti children 0-14 years over the last 20 years. Ped Diabetes. 2017;18(8):761–766. doi: 10.1111/pedi.12480. - DOI - PubMed
  2.  
    1. Taha TH, Moussa MA, Rashid AR, Fenech FF. Diabetes mellitus in Kuwait. Incidence in the first 29 years of life. Diabetologia. 1983;25(4):306–308. doi: 10.1007/BF00253190. - DOI - PubMed
  3.  
    1. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J. Incidence of childhood type 1 diabetes worldwide. Diabetes Care. 2000;23(10):1516–1526. doi: 10.2337/diacare.23.10.1516. - DOI - PubMed
  4.  
    1. Bener A, Al-Ali M, Hoffmann GF. High prevalence of vitamin D deficiency in young children in a highly sunny humid country: a global health problem. Minerva Pediatr. 2009;61(1):15–22. - PubMed
  5.  
    1. Gordon CM, Feldman HA, Sinclair L, Williams AL, Kleinman PK, Perez-Rossello J, Cox JE. Prevalence of vitamin D deficiency among healthy infants and toddlers. Arch Pediatr Adolesc Med. 2008;162(6):505–512. doi: 10.1001/archpedi.162.6.505. - DOI - PMC - PubMed
  6.  
    1. Jabbar Z, Aggarwal PK, Chandel N, Kohli HS, Gupta KL, Sakhuja V, Jha V. High prevalence of vitamin D deficiency in north Indian adults is exacerbated in those with chronic kidney disease. Nephrology. 2009;14(3):345–349. doi: 10.1111/j.1440-1797.2008.01082.x. - DOI - PubMed
  7.  
    1. Rovner AJ, O’Brien KO. Hypovitaminosis D among healthy children in United States: a review of the current evidence. Arch Pediatr Adolesc Med. 2008;162(6):513–519. doi: 10.1001/archpedi.162.6.513. - DOI - PubMed
  8.  
    1. Rasoul MA, Al-Mahdi M, Al-Kandari H, Dhaunsi GS, Haider MZ. Low serum vitamin- D status is associated with high prevalence and early onset of type-1 diabetes mellitus in Kuwaiti children. BMC Pediatr. 2016;16:95. doi: 10.1186/s12887-016-0629-3. - DOI - PMC - PubMed
  9.  
    1. Lemire J. 1,25-Dihydrovitamin D3-a hormone with immunomodulatory properties. Z Rheumatol. 2000;59(Suppl 1):24–27. doi: 10.1007/s003930070034. - DOI - PubMed
  10.  
    1. Mathieu C, van Etten E, Decallonne B, Guilietti A, Gysemans C, Bouillon R, Overbergh L. Vitamin D and 1,25-dihydrovitamin D3 as modulators in the immune system. J Steroid Biochem Mol Biol. 2004;89–90(1–5):449–452. doi: 10.1016/j.jsbmb.2004.03.014. - DOI - PubMed
  11.  
    1. Littorin B, Blom P, Scholin A, Arngvist HJ, Blohme G, Ekbom-Schnell A, et al. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide diabetes incidence study in Sweden (DISS) Diabetologia. 2006;49(12):2847–2852. doi: 10.1007/s00125-006-0426-x. - DOI - PubMed
  12.  
    1. Pozzilli P, Manfrini S, Crino A, Picardi A, Leomanni C, Cherubini V, et al. Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes. Horm Metab Res. 2005;37(11):680–683. doi: 10.1055/s-2005-870578. - DOI - PubMed
  13.  
    1. Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005;26:662–687. doi: 10.1210/er.2004-0002. - DOI - PubMed
  14.  
    1. Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R. Prevention of autoimmune diabetes in NOD mice by 1,25 dihydrovitamin D3. Diabetologia. 1994;37:552–558. doi: 10.1007/BF00403372. - DOI - PubMed
  15.  
    1. The EURODIAB Sub-study 2 study group. Vitamin D supplement in early childhood and risk for type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1999;42:51–54. doi: 10.1007/s001250051112. - DOI - PubMed
  16.  
    1. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet. 2001;358:1500–1503. doi: 10.1016/S0140-6736(01)06580-1. - DOI - PubMed
  17.  
    1. Fronczak CM, Baron AE, Chase HP, et al. In utero dietary exposures and risk of islet autoimmunity in children. Diabetes Care. 2003;26:3237–3242. doi: 10.2337/diacare.26.12.3237. - DOI - PubMed
  18.  
    1. Lemos MC, Fagulha A, Coutinho E, Gomes L, Bastos M, Barros L, et al. Lack of association of vitamin D receptor gene polymorphisms with susceptibility to diabetes mellitus in the Portuguese population. Hum Immunol. 2008;69:134–138. doi: 10.1016/j.humimm.2008.01.008. - DOI - PubMed
  19.  
    1. Crofts LA, Hancock MS, Morrison NA, Eisman JA. Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor transcripts. Proc Natl Acad Sci U S A. 1998;95:10529–10534. doi: 10.1073/pnas.95.18.10529. - DOI - PMC - PubMed
  20.  
    1. Walters MR. Newly identified actions of the vitamin D endocrine system. Endocr Rev. 1992;13:719–764. - PubMed
  21.  
    1. Van Etten E, Verlinden L, Giulietti A, Ramos-Lopez E, Branisteanu DD, Ferreira GB, et al. The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. Eur J Immunol. 2007;37:395–405. doi: 10.1002/eji.200636043. - DOI - PubMed
  22.  
    1. McDermott MF, Ramachandran A, Ogunkolade BW, Aganna E, Curtis D, Boucher BJ, et al. Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians. Diabetologia. 1997;40:971–975. doi: 10.1007/s001250050776. - DOI - PubMed
  23.  
    1. Ban Y, Taniyama M, Yanagawa T, Yamada S, Maruyama T, Kasuga A, Ban Y. Vitamin D receptor initiation codon polymorphism influences genetic susceptibility to type 1 diabetes mellitus in the Japanese population. BMC Med Genet. 2001;2:7. doi: 10.1186/1471-2350-2-7. - DOI - PMC - PubMed
  24.  
    1. Mohammadnejad Z, Ghanbari M, Ganjali R, Afshari JT, Heydarpour M, Taghavi SM, et al. Association between vitamin D receptor gene polymorphisms and type 1 diabetes mellitus in Iranian population. Mol Biol Rep. 2012;39:831–837. doi: 10.1007/s11033-011-0805-3. - DOI - PubMed
  25.  
    1. Turpeinen H, Hermann R, Vaara S, Laine AP, Simell O, Knip M, et al. Vitamin D receptor polymorphisms: no association with type 1 diabetes mellitus in the Finnish population. Eur J Endocrinol. 2003;149:591–596. doi: 10.1530/eje.0.1490591. - DOI - PubMed
  26.  
    1. Boraska V, Skrabic V, Zeggini E, Groves CJ, Buljubasic M, Peruzovic M, Zemunik T. Family-based analysis of vitamin D receptor gene polymorphisms and type 1 diabetes in population of South Croatia. J Hum Genet. 2008;53:210–214. doi: 10.1007/s10038-007-0234-2. - DOI - PubMed
  27.  
    1. Angel B, Santos JL, Carrasco E, Albala C, Perez-Bravo F. Vitamin D receptor polymorphism and susceptibility to diabetes in Chilean subjects: a case-parent study. Eur J Epidemiol. 2004;19:1085–1087. doi: 10.1007/s10654-004-1026-z. - DOI - PubMed
  28.  
    1. Khalid KE. Vitamin D receptor gene polymorphisms in Sudanese children with type 1 diabetes. AIMS Genet. 2016;3(3):167–176. doi: 10.3934/genet.2016.3.167. - DOI
  29.  
    1. Mukhtar M, Batool A, Wajid A, Qayyum I. Vitamin D receptor gene polymorphisms influence T1D susceptibility among Pakistanis. Int J Genomics. 2017. 10.1155/2017/4171254. - PMC - PubMed
  30.  
    1. Xiao XH, Liu ZL, Wang H, Sun Q, Li WH, Yang GH, Liu QY. Effects of vitamin D receptor gene polymorphisms on susceptibility to type 1 diabetes mellitus. Chinese Med Sci J. 2006;21:95–98. - PubMed
  31.  
    1. Chang TJ, LeiHH YJI, Chiu KC, Lee KC, Chen MC, Tai TY, Chuang LM. Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population. Clin Endrocrinol. 2000;52:575–580. doi: 10.1046/j.1365-2265.2000.00985.x. - DOI - PubMed
  32.  
    1. Iyar A, Lanham-New S, Khoja S, Al-Ghamdi M, Al Doghaither H. Relationship between vitamin D receptor gene polymorphisms and type 1 diabetes mellitus in Saudi patients. Int J Pharmacol. 2017. 10.3923/ijp.2017.1092.1097.
  33.  
    1. Cheon C-K, Nam H-K, Lee K-H, Kim SY, Song JS, Kim C. Vitamin D receptor gene polymorphisms and type 1 diabetes mellitus in a Korean population. Pediatr Int. 2015;57:870–874. doi: 10.1111/ped.12634. - DOI - PubMed
  34.  
    1. Marti G, Audi L, Esteban C, Oyarzabal M, Chueca M, Gussinye M, et al. Association of vitamin D receptor gene polymorphism with type 1 diabetes mellitus in two Spanish populations. Medicina Clinica. 2004;123:286–289. doi: 10.1016/S0025-7753(04)74494-2. - DOI - PubMed
  35.  
    1. Thorsen SU, Mortensen HB, Carstensen B, Fenger M, Thuesen BH, Husemoen L, et al. No association between type 1 diabetes and genetic variation in the vitamin D metabolism genes: a Danish study. Pediatr Diabetes. 2014;15:416–421. doi: 10.1111/pedi.12105. - DOI - PubMed
  36.  
    1. Penna-Martinez M, Badenhoop K. Inherited variation in vitamin D genes and type 1 diabetes predisposition. Genes. 2017;8:125. doi: 10.3390/genes8040125. - DOI - PMC - PubMed
  37.  
    1. Sahin OA, Goksen D, Ozpinar A, Serdar M, Onay H. Association of vitamin D receptor polymorphisms and type 1 diabetes susceptibility in children: a meta-analysis. Endocrine Connections. 2017;6:159–171. doi: 10.1530/EC-16-0110. - DOI - PMC - PubMed
  38.  
    1. Wang G, Zhang Q, Xu N, Xu K, Wang J, He W, Yang T. Association between two polymorphisms (FokI and BsmI) of the vitamin D receptor gene and type 1 diabetes mellitus in Asian population: a meta-analysis. PLoS One. 2014;9(3):e89325. doi: 10.1371/journal.pone.0089325. - DOI - PMC - PubMed
  39.  
    1. Haider MZ, Rasoul MA, Al-Mahdi M, Al-Kandari H, Dhaunsi GS. Association of protein tyrosine phosphatase non-receptor type 22 gene functional variant C1858T, HLA-DQ/DR genotypes and autoantibodies with type-1 diabetes mellitus in Kuwaiti Arabs. PLoS One. 2018;13(6):e0198652 10.1371/journal.pone.0198652. - PMC - PubMed
  40.  
    1. Craig ME, Jefferies C, Dabelea D, Balde N, Seth A, Donaghue KC. Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2014;15(Suppl 20):4–17. doi: 10.1111/pedi.12186. - DOI - PubMed
  41.  
    1. Rojnic Putarek N, Ille J, Spehar Uroic A, Skrabic V, Stipancic G, et al. Incidence of type 1 diabetes mellitus in 0 to 14-y-old children in Croatia – 2004 to 2012 study. Pediatr Diabetes. 2015;16:448–453. doi: 10.1111/pedi.12197. - DOI - PubMed
  42.  
    1. Maniatis T. Molecular Cloning – A Laboratory Manual. In: Sambrook J, Fritsch EF, editors. Cold Spring Harbor laboratory. 2. New York: USA; 1989.
  43.  
    1. Panierakis C, Goulielmos G, Mamoulakis D, Petraki E, Papavasiliou E, Galanakis E. Vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Crete. Greece Clin Immunol. 2009;133:276–281. doi: 10.1016/j.clim.2009.08.004. - DOI - PubMed
  44.  
    1. Yavuz DG, Keskin L, Kiyici S, Sert M, Yazici D, Sahin I, et al. Vitamin D receptor gene BsmI, FokI, ApaI, TaqI polymorphisms and bone mineral density in a group of Turkish type 1 diabetes patients. Acta Diabetol. 2011;48:329–336. doi: 10.1007/s00592-011-0284-y. - DOI - PubMed
  45.  
    1. Dilmec F, Uzner E, Akkafa F, Kise E, van Kuilenburg ABP. Detection of VDR gene ApaI and TaqI polymorphisms in patients with type 2 diabetes mellitus using PCR-RFLP method in a Turkish population. J Diabetes & Complications. 2010;24:186–191. doi: 10.1016/j.jdiacomp.2008.12.002. - DOI - PubMed
  46.  
    1. Jurutka PW, Remus GK, Whitfield PD, Thompson JC, Hsieh H, Zitzer P, et al. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol. 2000;14:401–420. doi: 10.1210/mend.14.3.0435. - DOI - PubMed
  47.  
    1. Moran-Auth Y, Penna-Martinez M, Badenhoop K. VDR FokI polymorphism is associated with a reduced T-helper cell population under vitamin D stimulation in type 1 diabetes patients. J Steroid Biochem Mol Biol. 2015;148:184–186. doi: 10.1016/j.jsbmb.2015.01.003. - DOI - PubMed
  48.  
    1. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004;338:143–156. doi: 10.1016/j.gene.2004.05.014. - DOI - PubMed
  49.  
    1. Gross C, Eccleshall TR, Malloy PJ, Villa ML, Marcus R, Feldman D. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res. 1996;11:1850–1855. doi: 10.1002/jbmr.5650111204. - DOI - PubMed
  50.  
    1. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res. 1998;13:325–349. doi: 10.1359/jbmr.1998.13.3.325. - DOI - PubMed
  51.  
    1. Zemunik T, Skrabic V, Boraska V, Diklic D, Terzic IM, Capkun V, et al. FokI polymorphism, vitamin D receptor, and Interleukin-1 receptor haplotypes are associated with type 1 diabetes in the Dalmatian population. J Mol Diagnostics. 2005;7:600–604. doi: 10.1016/S1525-1578(10)60593-4. - DOI - PMC - PubMed
  52.  
    1. Mory DB, Rocco ER, Miranda WL, Kasamatsu T, Crispim F, Dib SA. Prevalence of vitamin D receptor gene polymorphisms FokI and BsmI in Brazilian individuals with type 1 diabetes and their relation to beta-cell autoimmunity and to remaining beta-cell function. Hum Immunol. 2009;70:447–451. doi: 10.1016/j.humimm.2009.03.007. - DOI - PubMed
  53.  
    1. Abd-Allah SH, Pasha HF, Hagrass HA, Alghobashy AA. Vitamin D status and vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Egyptian children. Gene. 2014;536:430–434. doi: 10.1016/j.gene.2013.12.032. - DOI - PubMed
  54.  
    1. Fassbender WJ, Goertz B, Weismuller K, Steinhauser B, Stracke H, Auch D, et al. VDR gene polymorphisms are overexpressed in German patients with type 1 diabetes compared to healthy controls without effect on biochemical parameters of bone metabolism. Horm Metab Res. 2002;34:330–337. doi: 10.1055/s-2002-33262. - DOI - PubMed
  55.  
    1. Pani MA, Knapp M, Donner H, Braun J, Baur MP, Usadel KH. Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes. 2000;49:504–507. doi: 10.2337/diabetes.49.3.504. - DOI - PubMed
  56.  
    1. Ogunkolade BW, Boucher BJ, Prahl JM, Bustin SA, Burrin JM, Noonan K, et al. Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes. 2002;51:2294–2300. doi: 10.2337/diabetes.51.7.2294. - DOI - PubMed
  57.  
    1. Valdivielso JM, Fernandez E. Vitamin D receptor polymorphisms and disease. Clin Chim Acta. 2006;371:1–12. doi: 10.1016/j.cca.2006.02.016. - DOI - PubMed
  58.  
    1. Silva JD, Guimaraes RL, Brandao LAV, Arauja J, Segat L, Crovella S, et al. Vitamin D receptor (VDR) gene polymorphisms and age onset in type 1 diabetes mellitus. Autoimmunity. 2013;46(6):382–387. doi: 10.3109/08916934.2013.795952. - DOI - PubMed
  59.  
    1. Motohashi Y, Yamada S, Yanagawa T, Maruyama T, Suzuki R, Niino M, et al. Vitamin D receptor gene polymorphism affects onset pattern of type 1 diabetes. J Clin Endocrinol Metab. 2003;88(7):3137–3140. doi: 10.1210/jc.2002-021881. - DOI - PubMed
  60.  
    1. Singh S, Singh UG, Agarwal NK, Singh RG, Kumar SB. Prevalence of autoantibodies and HLA DR, DQ in type 1 diabetes mellitus. J Clin Diagnostic Res. 2016;10(7):EC9–EC13. doi: 10.7860/JCDR/2016/18657.8163. - DOI - PMC - PubMed
  61.  
    1. Bingley PJ. Clinical applications of diabetes in antibody testing. J Clin Endocrinol Metab. 2010;95:25–33. doi: 10.1210/jc.2009-1365. - DOI - PubMed
  62.  
    1. Ziegler AG, Nepom GT. Prediction and pathogenesis in type 1 diabetes. Immunity. 2010;32:468–478. doi: 10.1016/j.immuni.2010.03.018. - DOI - PMC - PubMed
  63.  
    1. Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A. 2007;104:17040–17045. doi: 10.1073/pnas.0705894104. - DOI - PMC - PubMed
  64.  
    1. Verge CF, Stenger D, Bonifacio E, Colman PG, Pilcher C, Bingley PG, et al. Combined use of autoantibodies (IA-2ab), (GADAb, IAA, ICA) in type 1 diabetes: combinatorial islet autoantibody workshop. Diabetes. 1998;47:1857–1866. doi: 10.2337/diabetes.47.12.1857. - DOI - PubMed
  65.  
    1. Manan H, Angham AM, Sitebanat A. Genetic and auto-antibody markers in Saudi children with type 1 diabetes. Hum Immunol. 2010;71:1238–1242. doi: 10.1016/j.humimm.2010.09.008. - DOI - PubMed
  66.  
    1. Chan JCN, Yeung VTF, Chow CC, Ko GTC, Mackey IR, Rowley MJ, et al. Pancreatic beta cell function and antibodies to glutamic acid decarboxylase (anti-GAD) in Chinese patients with clinical diagnosis of insulin-dependent diabetes mellitus. Diabetes Res Clin Pract. s1996;32:27–34. - PubMed

Page Navigation